Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | EWTX | TWST | ||
| Company | Dicerna Pharmaceutic | Edgewise Therapeutics Inc | Twist Bioscience Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 28.20 | 47.13 | ||
| High | 38.24 | 29.65 | 48.13 | ||
| Low | 38.21 | 27.00 | 45.79 | ||
| Latest | 38.22 | 27.19 | 47.10 | ||
| Change | +0.22 | -1.28 | -1.02 | ||
| % Change | +0.58% | -4.50% | -2.12% | ||
| Volume | 5,568,900 | 836,500 | 2,164,100 | ||
| 20-Day Average Volume | 3,647,665 | 1,118,715 | 1,494,180 | ||
| Previous Close | 38.00 | 28.47 | 48.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 27.73 | 42.12 | ||
| 20-Day Raw Stochastic | 90.72% | 54.19% | 88.50% | ||
| 20-Day Relative Strength | 80.40 | 52.90 | 67.65 | ||
| Weighted Alpha | +35.17 | +71.97 | +23.91 | ||
| Today's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -5.52% since 01/29/26 | +13.28% since 01/29/26 | ||
| Low | 37.81 on 12/21/21 | 27.00 on 02/05/26 | 39.66 on 01/30/26 | ||
| High | 38.24 on 12/27/21 | 29.98 on 02/03/26 | 48.73 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +15.36% since 01/05/26 | +37.16% since 01/05/26 | ||
| Low | 37.78 on 12/10/21 | 22.78 on 01/06/26 | 34.50 on 01/06/26 | ||
| High | 38.26 on 12/03/21 | 30.25 on 01/23/26 | 48.73 on 02/04/26 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +56.53% since 11/05/25 | +49.43% since 11/05/25 | ||
| Low | 19.06 on 10/06/21 | 16.70 on 11/07/25 | 23.30 on 11/14/25 | ||
| High | 38.26 on 12/03/21 | 30.25 on 01/23/26 | 48.73 on 02/04/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +97.89% since 08/05/25 | +71.15% since 08/05/25 | ||
| Low | 19.06 on 10/06/21 | 12.30 on 08/11/25 | 23.30 on 11/14/25 | ||
| High | 40.14 on 07/20/21 | 30.25 on 01/23/26 | 48.73 on 02/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,014,062 | 2,950,334 | ||
| Shares Outstanding, K | 78,129 | 105,868 | 61,312 | ||
| Annual Sales | 164,310,000 | 0 | 376,570,000 | ||
| Annual Net Income | -112,750,000 | -133,810,000 | -77,670,000 | ||
| Last Quarter Sales | 62,950,000 | 0 | 99,010,000 | ||
| Last Quarter Net Income | -17,070,000 | -40,670,000 | -27,140,000 | ||
| 60-Month Beta | 0.80 | 0.27 | 2.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -0.39 on 11/06/25 | -0.50 on 02/02/26 | ||
| Latest Earnings Date | 02/24/22 | 03/02/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||